RT Journal Article
SR Electronic
T1 Morphological, cellular and molecular basis of brain infection in COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.09.20207464
DO 10.1101/2020.10.09.20207464
A1 Crunfli, Fernanda
A1 Carregari, Victor Corasolla
A1 Veras, Flavio Protasio
A1 Vendramini, Pedro Henrique
A1 Valença, Aline Gazzola Fragnani
A1 Antunes, André Saraiva Leão Marcelo
A1 Brandão-Teles, Caroline
A1 da Silva Zuccoli, Giuliana
A1 Reis-de-Oliveira, Guilherme
A1 Silva-Costa, Lícia C.
A1 Saia-Cereda, Verônica Monteiro
A1 Smith, Bradley Joseph
A1 Codo, Ana Campos
A1 de Souza, Gabriela Fabiano
A1 Muraro, Stéfanie Primon
A1 Parise, Pierina Lorencini
A1 Toledo-Teixeira, Daniel A.
A1 de Castro, Ícaro Maia Santos
A1 Melo, Bruno Marcel Silva
A1 Almeida, Glaucia M.
A1 Firmino, Egidi Mayara Silva
A1 Paiva, Isadora Marques
A1 Silva, Bruna Manuella Souza
A1 Guimarães, Rafaela Mano
A1 Mendes, Niele D.
A1 Ludwig, Raíssa Guimarães
A1 Ruiz, Gabriel Palermo
A1 Knittel, Thiago Leite
A1 Davanzo, Gustavo Gastão
A1 Gerhardt, Jaqueline Aline
A1 Rodrigues, Patrícia Brito
A1 Forato, Julia
A1 Amorim, Mariene Ribeiro
A1 Silva, Natália Brunetti
A1 Martini, Matheus Cavalheiro
A1 Benatti, Maíra Nilson
A1 Batah, Sabrina
A1 Siyuan, Li
A1 João, Rafael Batista
A1 Silva, Lucas Scardua
A1 Nogueira, Mateus Henrique
A1 Aventurato, Ítalo Karmann
A1 de Brito, Mariana Rabelo
A1 Alvim, Marina Koutsodontis Machado
A1 da Silva Júnior, José Roberto
A1 Damião, Lívia Liviane
A1 de Sousa, Iêda Maria Pereira
A1 da Rocha, Elessandra Dias
A1 Gonçalves, Solange Maria
A1 da Silva, Luiz Henrique Lopes
A1 Bettini, Vanessa
A1 de Campos, Brunno Machado
A1 Ludwig, Guilherme
A1 Tavares, Lucas Alves
A1 Pontelli, Marjorie Cornejo
A1 Viana, Rosa Maria Mendes
A1 Martins, Ronaldo
A1 Vieira, Andre S.
A1 Alves-Filho, José Carlos
A1 Arruda, Eurico
A1 Podolski-Gondim, Guilherme
A1 Santos, Marcelo Volpon
A1 Neder, Luciano
A1 Cendes, Fernando
A1 Louzada-Junior, Paulo
A1 Oliveira, Renê Donizeti
A1 Cunha, Fernando Queiroz
A1 Damásio, André
A1 Vinolo, Marco Aurélio Ramirez
A1 Munhoz, Carolina Demarchi
A1 Rehen, Stevens K.
A1 Nakaya, Helder I
A1 Mauad, Thais
A1 Duarte-Neto, Amaro Nunes
A1 da Silva, Luiz Fernando Ferraz
A1 Dolhnikoff, Marisa
A1 Saldiva, Paulo
A1 Farias, Alessandro S.
A1 Moraes-Vieira, Pedro Manoel M.
A1 Fabro, Alexandre Todorovic
A1 Sebollela, Adriano S.
A1 Módena, José Luiz Proença
A1 Yasuda, Clarissa Lin
A1 Mori, Marcelo A.
A1 Cunha, Thiago Mattar
A1 Martins-de-Souza, Daniel
YR 2022
UL http://medrxiv.org/content/early/2022/01/20/2020.10.09.20207464.abstract
AB Although increasing evidence confirms neuropsychiatric manifestations associated mainly with severe COVID-19 infection, the long-term neuropsychiatric dysfunction has been frequently observed after mild infection. Here we show the spectrum of the cerebral impact of SARS-CoV-2 infection ranging from long-term alterations in mildly infected individuals (orbitofrontal cortical atrophy, neurocognitive impairment, excessive fatigue and anxiety symptoms) to severe acute damage confirmed in brain tissue samples extracted from the orbitofrontal region (via endonasal trans-ethmoidal approach) from individuals who died of COVID-19. We used surface-based analyses of 3T MRI and identified orbitofrontal cortical atrophy in a group of 81 mildly infected patients (77% referred anosmia or dysgeusia during acute stage) compared to 145 healthy volunteers; this atrophy correlated with symptoms of anxiety and cognitive dysfunction. In an independent cohort of 26 individuals who died of COVID-19, we used histopathological signs of brain damage as a guide for possible SARS-CoV-2 brain infection, and found that among the 5 individuals who exhibited those signs, all of them had genetic material of the virus in the brain. Brain tissue samples from these 5 patients also exhibited foci of SARS-CoV-2 infection and replication, particularly in astrocytes. Supporting the hypothesis of astrocyte infection, neural stem cell-derived human astrocytes in vitro are susceptible to SARS-CoV-2 infection through a non-canonical mechanism that involves spike-NRP1 interaction. SARS-CoV-2-infected astrocytes manifested changes in energy metabolism and in key proteins and metabolites used to fuel neurons, as well as in the biogenesis of neurotransmitters. Moreover, human astrocyte infection elicits a secretory phenotype that reduces neuronal viability. Our data support the model in which SARS-CoV-2 reaches the brain, infects astrocytes and consequently leads to neuronal death or dysfunction. These deregulated processes are also likely to contribute to the structural and functional alterations seen in the brains of COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFAPESP (Sao Paulo Research Foundation; grants 2020/04746 0; 2017/25588 1; 2019/00098 7; 2014/10068 4; 2020/04919 2; 2013/08216 2; 2020/05601 6; 2020/04860 8; 2019/11457 8; 2013/07559 3; 2013/07607 8), Fundo de Apoio ao Ensino, Pesquisa e Extensao (FAEPEX) Unicamp Grant number: 2274/20, the Brazilian National Council for Scientific and Technological Development CNPq, and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The neuropsychological evaluations and neuroimaging analyses were approved by the Research Ethics Committee of the University of Campinas (CAAE: 31556920.0.0000.5404) and all subjects signed a consent form to participate. The autopsy studies were approved by the National Commission for Research Ethics (CAAE:32475220.5.0000.5440 and CAAE: 38071420.0.1001.5404).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe mass spectrometry proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD023781 and 10.6019/PXD023781.